Governmental agencies are also exhibiting an increasingly critical degree of scrutiny of advertisements in medical journals. Pharmaceutical firms (at least a gratifyingly large number) have voluntarily policed their own advertisements to a remarkable extent. However, this responsibility cannot be relegated exclusively to one sector of medicine. Each advertisement published in CHEST is screened by a scientific evaluation committee.
The twentieth century has been a sad saga of international fads involving short-lived miracle drugs or diets. If such events are to be prevented in the eighth decade, editorial boards and scientific program committees must accept major responsibility for the evaluation of new diagnostic and therapeutic measures. However, human fallibility is an eternal attribute of man, and we must assume that in the future some judgmental errors will be made by the government, editors, and scientific program committees. Some of the deleterious effects of these mistakes can be obviated if every clinician recognizes that the individual experiences of the physician must be the final arbiter in the critical evaluation of the validity and significance of therapeutic recommendations. Thus, understanding of the discipline of research is of fundamental importance, not only to editors, referees, and investigators, but also to the bedside clinician. The reader who can distinguish between sound and faulty investigational techniques is enabled to draw his own conclusions. The editors of CHEST do not accept the premise that it is inevitable that practitioners will become technicians who accept the conclusions of every published report without reservation. We shall continue to insist that every manuscript be so constructed that the willingness and the ability of the physician to be a critical reader are honored. Non-surgical procedures are largely radiologic techniques including special views, tomography, contrast studies of vessels and bronchi, systemic surveys and scans. By their very nature, these examinations must be performed on separate occasions. None of them yields tissue specific for diagnosis or determination of metastatic spread.
Surgical methods designed to obtain such histologic material include bronchoscopy, scalene biopsy, pleural biopsy, mediastinoscopy, and, in many instances, open thoracotomy itself. It is customary in most clinics to proceed in a discontinuous, timeconsuming fashion from one surgical. procedure to the next, awaiting reports of p a r a n sections each time until the way has been cleared for open thoracotomy. Thus, while the desired information is ultimately forthcoming, the patient usually makes two or three separate trips to the operating room, sometimes under the care of different surgeons, before finally being scheduled for a definitive procedure. FalorZ recognized these shortcomings and advocated a one-stage approach.
Since we began doing mediastinoscopy in 1965,3 it has become the keystone of our surgical diagnostic appraisal in lung cancer. It has almost completely replaced scalene biopsy and is performed routinely in all cases of proved or suspected lung cancer even if the mediastinum is radiologically normal. After an initial period of familiarization h t h the technique, we have come to combine it with bronchoscopy and thoracotomy all at the same sitting under the same general anesthesia.
First, the ventilating bronchoscope is passed, the bronchial tree inspected and appropriate biopsies taken. A topopphic evaluation for resection is made (ie lobectomy, pneumonectomy or sleeve resection). Next, the bronchoscope is replaced by a single-lumen anode type endotracheal tube and mediastinoscopy with biopsy and frozen section is carried out. If there is no mediastinal involvement, the mediastinoscopy wound is closed, the single-lumen endotracheal tube is replaced by a double-lumen type (Carlens, Gordon-Green or Robertshaw) and
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the chest is opened for definitive lung resection.
Under this plan, in over 40 cases with negative mediastinoscopies, curative resection has been possible in almost 90 per cent.
The combined approach is terminated at any point where evidence of inoperability is obtainedie gross involvement of trachea and/or carina, malignant mediastinal adenopathy, non-malignant diagnosis not requiring resection (ie tuberculosis, sarcoidosis), or those rare instances in which frozen section is inconclusive or questionable and review of par* section is mandatory. Requirements essential for the success of this c o ordinated approach are as follows: 1) the surgeon should be skilled in all of the procedures; 2) the pathologist must be thoroughly conversant with frozen section techniques; 3) the anesthetist should be familar with the various endothracheal tubes and anesthetic techniques, and 4) the operating room organization and staff must be amenable to such a combination of procedures. 
REMOTE ETIOLOGIC FACTORS IN PLEURAL EFFUSION
It is beyond the framework of this brief note to deal with the nosology of pleural effusion. Instead, attention will be focused on transudates in the pleural space. They represent collection of nonidammatory serous fluid which is thin, clear and usually straw colored. Its specific gravity is less than 1.018, usually between 1.012 and 1.014. Its protein content is less than 4 gm per 100 ml, commonly about 2.5 gm per 100 ml. It contains less 500 lymphocytes per cu mm. These data may serve as a guide but cannot be relied upon with absolute certainty. Most common cause of hydrothorax is heart failure and renal disease: the former when it results in increased pulmonary venous pressure; nephrosis brings about formation of pleural transudate through osmotic imbalance due to colloidal changes. Other possible pathogenic factors in this regard include cirrhosis of the liver, severe malnutrition through hypoproteinemia, severe vitamin C deficiencv, thrombosis of large endothoracic veins, large mediastinal tumors which block lymph flow or venous flow. The clinical observations of Meigs of Boston established the association of ovarian neoplasms with pleural effusion as a svndrome in 1937. This finding was substantially documented in his subsequent ublications. Deservedlv, his name serves as its idenJving eponym even though similar data were reported by others in several publications since 1866. Meigs' first report dealt with seven cases of fibroma of the ovary with associated ascites and right pleural effusion. Subsequently it was noted that pleural effusion mav be associated with other benign neoplasms of the ovaries. These include theca cell tumors. which are firm. enca~sulated structures im-A bedded in textured connective tissue; granulosa cell tumors of solid consistency, usually localized within the confines of the ovaries; Brenner tumors which vary from microscopic to large size; multilocular cvstadenomas and some unclassified tumors. Also, ovarian sarcoma and carcinoma may result in ascites and pleural effusion with or without cytologic evidence of metastasis. According to prevailing concepts, effusion in the pleural space results from the passage of ascitic fluid through the lymph channels of the diaphragm, through the latter's occasional minute congenital de-Y 0 fects or small ruptures which may follow stretching of the diaphragm bv large ascites. Confirmatory evidence has been demonstrated bv means of carbon and radioactive isotope-labeled albumin instilled into ascitic fluid in situ. Some clinicians are of the o~inion that antigens derived from tissue debris of darian tumors, which are transmitted through the lymphatics to the pleural space, provoke ~leural h-yperemia, vasodilatation and exudation. The effusion is found on the right side in 70 per cent, on the left in 20 per cent and it is bilateral in 10 per cent. Meigs' s~ldrome is usually postmenopausal. Cough, chest pain and/or dyspnea may be presenting symptoms. As to treatment, removal of the ovarian tumor is mandatory. It results in complete disappearance of the pleural ehsion. 
